Sheila Jacobs

Contributing Writer https://www.endocrinologyadvisor.com

Sheila Jacobs is the president of STJ Editorial Services. For more than 25 years, Sheila has been providing writing, fact-checking, and editorial services to numerous clients in the medical education, promotional, and managed care arenas, from the conceptual stage through completion of the final editorial product. Her focus has been in a diverse array of therapeutic areas.

All articles by Sheila Jacobs

Diabetes

Comparing Statin Prescriptions, Lipid Testing in SLE vs Diabetes

Sheila Jacobs

May 11, 2018

Researchers investigated whether patients with SLE receive lipid testing and statin prescriptions comparably with patients with diabetes.

General Endocrinology

Hormonal Antiandrogen Therapy for Acne May Help Reduce Antibiotic Use

Sheila Jacobs

May 7, 2018

Recognizing the increased need for antibiotic stewardship, the researchers consider HAAT to be a useful alternative to systemic antibiotic therapy that is effective and well tolerated among women with inflammatory acne.

Bone Metabolism

Tibiofemoral MRI May Be Predictive of Radiographic Knee OA in Overweight, Obese Women

Sheila Jacobs

May 4, 2018

Researchers sought to determine the predictive value of tibiofemoral MRI, patellofemoral MRI, and KLG1 for the incidence of clinical or radiographic knee OA.

Diabetes

Hidradenitis Suppurativa Associated With Insulin Resistance

Sheila Jacobs

April 16, 2018

The study results suggest that hidradenitis suppurativa is both a cutaneous disease and a chronic systemic inflammatory condition.

Neuroendocrinology

Evidence of Impaired Glucose Signaling in Amyotrophic Lateral Sclerosis

Sheila Jacobs

April 11, 2018

Further research is warranted to clarify the role played by insulin resistance in the pathogenesis of amyotrophic lateral sclerosis.

Androgen and Reproductive Disorders

Fertility in Women Negatively Affected by Asthma Medications

Sheila Jacobs

March 22, 2018

The management of asthma with short-acting beta-agonists was associated with reduced fertility rates in women, whereas treatment with inhaled corticosteroids or long-acting beta-agonists was not.

Bone Metabolism

Effect of Biologic DMARDs on Spinal Fracture Risk in Ankylosing Spondylitis

Sheila Jacobs

February 22, 2018

The use of biologic disease-modifying antirheumatic drugs has no medium-term effect on the risk for spinal fractures among patients with ankylosing spondylitis.

Bone Metabolism

Romosozumab Followed by Alendronate Decreases Fracture Risk in Women With Osteoporosis

Sheila Jacobs

January 22, 2018

In postmenopausal women at high risk for fracture, treatment with romosozumab for 12 months, followed by alendronate, was associated with significantly fewer hip fractures than treatment with alendronate alone.

Next post in Bone Metabolism

$spine-fracture$